title: Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans.
abstract: Eating disorders, such as anorexia nervosa (AN), bulimia nervosa (BN) and binge eating disorders (BED), are described as abnormal eating habits that usually involve insufficient or excessive food intake. Animal models have been developed that provide insight into certain aspects of eating disorders. Several drugs have been found efficacious in these animal models and some of them have eventually proven useful in the treatment of eating disorders. This review will cover the role of monoaminergic neurotransmitters in eating disorders and their pharmacological manipulations in animal models and humans. Dopamine, 5-HT (serotonin) and noradrenaline in hypothalamic and striatal regions regulate food intake by affecting hunger and satiety and by affecting rewarding and motivational aspects of feeding. Reduced neurotransmission by dopamine, 5-HT and noradrenaline and compensatory changes, at least in dopamine D2 and 5-HT(2C/2A) receptors, have been related to the pathophysiology of AN in humans and animal models. Also, in disorders and animal models of BN and BED, monoaminergic neurotransmission is down-regulated but receptor level changes are different from those seen in AN. A hypofunctional dopamine system or overactive α2-adrenoceptors may contribute to an attenuated response to (palatable) food and result in hedonic binge eating. Evidence for the efficacy of monoaminergic treatments for AN is limited, while more support exists for the treatment of BN or BED with monoaminergic drugs.
authors.affiliation: Brain Center Rudolf Magnus, Department of Translational Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands.
authors.forename: M A
authors.initials: MA
authors.lastname: van Gestel
authors.forename: E
authors.initials: E
authors.lastname: Kostrzewa
authors.forename: R A H
authors.initials: RA
authors.lastname: Adan
authors.forename: S K
authors.initials: SK
authors.lastname: Janhunen
mesh_terms: D000818:Animals; D000855:Anorexia / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D056912:Binge-Eating Disorder / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D004195:Disease Models, Animal; D004298:Dopamine / Q000502:physiology; D004435:Eating / Q000187:drug effects; D005247:Feeding Behavior / Q000187:drug effects; D006801:Humans; D018377:Neurotransmitter Agents / Q000627:therapeutic use; D009638:Norepinephrine / Q000502:physiology; D012701:Serotonin / Q000502:physiology
chemical_list: D018377:Neurotransmitter Agents; D012701:Serotonin; D004298:Dopamine; D009638:Norepinephrine